nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP3A4—prostate cancer	0.122	1	CbGaD
Ropinirole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0437	0.113	CbGbCtD
Ropinirole—CYP1A2—Flutamide—prostate cancer	0.0363	0.0937	CbGbCtD
Ropinirole—CYP2D6—Bicalutamide—prostate cancer	0.0361	0.0931	CbGbCtD
Ropinirole—CYP2D6—Abiraterone—prostate cancer	0.0299	0.0772	CbGbCtD
Ropinirole—CYP1A2—Estrone—prostate cancer	0.0263	0.0677	CbGbCtD
Ropinirole—CYP3A4—Bicalutamide—prostate cancer	0.023	0.0592	CbGbCtD
Ropinirole—CYP3A4—Estramustine—prostate cancer	0.0214	0.0551	CbGbCtD
Ropinirole—CYP3A4—Flutamide—prostate cancer	0.019	0.0491	CbGbCtD
Ropinirole—CYP3A4—Abiraterone—prostate cancer	0.019	0.0491	CbGbCtD
Ropinirole—CYP1A2—Conjugated Estrogens—prostate cancer	0.0172	0.0443	CbGbCtD
Ropinirole—CYP1A2—Estradiol—prostate cancer	0.0151	0.0389	CbGbCtD
Ropinirole—CYP3A4—Cabazitaxel—prostate cancer	0.0141	0.0363	CbGbCtD
Ropinirole—CYP3A4—Estrone—prostate cancer	0.0138	0.0355	CbGbCtD
Ropinirole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0123	0.0316	CbGbCtD
Ropinirole—CYP1A2—Etoposide—prostate cancer	0.00985	0.0254	CbGbCtD
Ropinirole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00901	0.0232	CbGbCtD
Ropinirole—CYP3A4—Mitoxantrone—prostate cancer	0.00819	0.0211	CbGbCtD
Ropinirole—CYP3A4—Estradiol—prostate cancer	0.00791	0.0204	CbGbCtD
Ropinirole—CYP3A4—Prednisone—prostate cancer	0.0068	0.0175	CbGbCtD
Ropinirole—CYP2D6—Doxorubicin—prostate cancer	0.00554	0.0143	CbGbCtD
Ropinirole—CYP3A4—Etoposide—prostate cancer	0.00516	0.0133	CbGbCtD
Ropinirole—CYP3A4—Docetaxel—prostate cancer	0.00472	0.0122	CbGbCtD
Ropinirole—CYP3A4—Doxorubicin—prostate cancer	0.00352	0.00908	CbGbCtD
Ropinirole—CYP1A2—urine—prostate cancer	0.000846	0.118	CbGeAlD
Ropinirole—HTR2A—urine—prostate cancer	0.000662	0.0923	CbGeAlD
Ropinirole—CYP3A4—urine—prostate cancer	0.000612	0.0854	CbGeAlD
Ropinirole—CYP2D6—urine—prostate cancer	0.000603	0.0841	CbGeAlD
Ropinirole—DRD4—testis—prostate cancer	0.000533	0.0744	CbGeAlD
Ropinirole—ADRA2C—prostate gland—prostate cancer	0.00035	0.0488	CbGeAlD
Ropinirole—ADRA2C—seminal vesicle—prostate cancer	0.000296	0.0413	CbGeAlD
Ropinirole—ADRA2A—prostate gland—prostate cancer	0.000279	0.039	CbGeAlD
Ropinirole—HTR1A—renal system—prostate cancer	0.000272	0.0379	CbGeAlD
Ropinirole—ADRA2C—renal system—prostate cancer	0.000239	0.0333	CbGeAlD
Ropinirole—ADRA2A—seminal vesicle—prostate cancer	0.000236	0.0329	CbGeAlD
Ropinirole—ADRA2C—urethra—prostate cancer	0.000234	0.0327	CbGeAlD
Ropinirole—CYP1A2—renal system—prostate cancer	0.000207	0.0289	CbGeAlD
Ropinirole—ADRA2A—urethra—prostate cancer	0.000187	0.0261	CbGeAlD
Ropinirole—HTR2A—epithelium—prostate cancer	0.000175	0.0243	CbGeAlD
Ropinirole—HTR2A—renal system—prostate cancer	0.000162	0.0226	CbGeAlD
Ropinirole—DRD2—testis—prostate cancer	0.000159	0.0221	CbGeAlD
Ropinirole—ADRA2C—testis—prostate cancer	0.000154	0.0215	CbGeAlD
Ropinirole—CYP3A4—renal system—prostate cancer	0.00015	0.0209	CbGeAlD
Ropinirole—CYP2D6—renal system—prostate cancer	0.000147	0.0206	CbGeAlD
Ropinirole—HTR2B—lymph node—prostate cancer	0.000142	0.0198	CbGeAlD
Ropinirole—ADRA2A—testis—prostate cancer	0.000123	0.0172	CbGeAlD
Ropinirole—ADRA2C—lymph node—prostate cancer	0.000112	0.0156	CbGeAlD
Ropinirole—HTR2A—testis—prostate cancer	0.000105	0.0146	CbGeAlD
Ropinirole—CYP2D6—testis—prostate cancer	9.53e-05	0.0133	CbGeAlD
Ropinirole—ADRA2A—lymph node—prostate cancer	8.92e-05	0.0124	CbGeAlD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.71e-05	7.87e-05	CcSEcCtD
Ropinirole—Dyspnoea—Docetaxel—prostate cancer	2.71e-05	7.85e-05	CcSEcCtD
Ropinirole—Somnolence—Docetaxel—prostate cancer	2.7e-05	7.83e-05	CcSEcCtD
Ropinirole—Discomfort—Prednisone—prostate cancer	2.7e-05	7.83e-05	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—prostate cancer	2.69e-05	7.82e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Etoposide—prostate cancer	2.69e-05	7.81e-05	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—prostate cancer	2.69e-05	7.8e-05	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—prostate cancer	2.68e-05	7.78e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.68e-05	7.77e-05	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—prostate cancer	2.67e-05	7.76e-05	CcSEcCtD
Ropinirole—Flushing—Epirubicin—prostate cancer	2.67e-05	7.76e-05	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—prostate cancer	2.67e-05	7.76e-05	CcSEcCtD
Ropinirole—Dyspepsia—Docetaxel—prostate cancer	2.67e-05	7.75e-05	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—prostate cancer	2.67e-05	7.74e-05	CcSEcCtD
Ropinirole—Insomnia—Capecitabine—prostate cancer	2.66e-05	7.71e-05	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—prostate cancer	2.65e-05	7.7e-05	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—prostate cancer	2.65e-05	7.68e-05	CcSEcCtD
Ropinirole—Paraesthesia—Capecitabine—prostate cancer	2.64e-05	7.66e-05	CcSEcCtD
Ropinirole—Decreased appetite—Docetaxel—prostate cancer	2.64e-05	7.66e-05	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—prostate cancer	2.63e-05	7.64e-05	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—prostate cancer	2.63e-05	7.62e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—prostate cancer	2.62e-05	7.61e-05	CcSEcCtD
Ropinirole—Asthenia—Etoposide—prostate cancer	2.62e-05	7.6e-05	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—prostate cancer	2.62e-05	7.6e-05	CcSEcCtD
Ropinirole—Dyspnoea—Capecitabine—prostate cancer	2.62e-05	7.6e-05	CcSEcCtD
Ropinirole—Oedema—Prednisone—prostate cancer	2.62e-05	7.6e-05	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—prostate cancer	2.62e-05	7.59e-05	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—prostate cancer	2.61e-05	7.59e-05	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—prostate cancer	2.61e-05	7.59e-05	CcSEcCtD
Ropinirole—Nausea—Mitoxantrone—prostate cancer	2.61e-05	7.57e-05	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—prostate cancer	2.6e-05	7.55e-05	CcSEcCtD
Ropinirole—Infection—Prednisone—prostate cancer	2.6e-05	7.55e-05	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—prostate cancer	2.6e-05	7.54e-05	CcSEcCtD
Ropinirole—Pain—Docetaxel—prostate cancer	2.6e-05	7.53e-05	CcSEcCtD
Ropinirole—Constipation—Docetaxel—prostate cancer	2.6e-05	7.53e-05	CcSEcCtD
Ropinirole—Dyspepsia—Capecitabine—prostate cancer	2.59e-05	7.51e-05	CcSEcCtD
Ropinirole—Chills—Epirubicin—prostate cancer	2.59e-05	7.5e-05	CcSEcCtD
Ropinirole—Pruritus—Etoposide—prostate cancer	2.58e-05	7.5e-05	CcSEcCtD
Ropinirole—Shock—Prednisone—prostate cancer	2.57e-05	7.47e-05	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—prostate cancer	2.57e-05	7.47e-05	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—prostate cancer	2.57e-05	7.46e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Prednisone—prostate cancer	2.57e-05	7.45e-05	CcSEcCtD
Ropinirole—Tachycardia—Prednisone—prostate cancer	2.55e-05	7.41e-05	CcSEcCtD
Ropinirole—Decreased appetite—Capecitabine—prostate cancer	2.55e-05	7.41e-05	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—prostate cancer	2.55e-05	7.39e-05	CcSEcCtD
Ropinirole—Skin disorder—Prednisone—prostate cancer	2.54e-05	7.38e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Capecitabine—prostate cancer	2.54e-05	7.36e-05	CcSEcCtD
Ropinirole—Fatigue—Capecitabine—prostate cancer	2.53e-05	7.35e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Prednisone—prostate cancer	2.53e-05	7.34e-05	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—prostate cancer	2.52e-05	7.33e-05	CcSEcCtD
Ropinirole—Constipation—Capecitabine—prostate cancer	2.51e-05	7.29e-05	CcSEcCtD
Ropinirole—Pain—Capecitabine—prostate cancer	2.51e-05	7.29e-05	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—prostate cancer	2.51e-05	7.28e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—prostate cancer	2.5e-05	7.26e-05	CcSEcCtD
Ropinirole—Diarrhoea—Etoposide—prostate cancer	2.5e-05	7.25e-05	CcSEcCtD
Ropinirole—Anorexia—Prednisone—prostate cancer	2.49e-05	7.24e-05	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—prostate cancer	2.49e-05	7.23e-05	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—prostate cancer	2.49e-05	7.21e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—prostate cancer	2.48e-05	7.2e-05	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—prostate cancer	2.47e-05	7.18e-05	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—prostate cancer	2.47e-05	7.18e-05	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—prostate cancer	2.47e-05	7.17e-05	CcSEcCtD
Ropinirole—Tension—Epirubicin—prostate cancer	2.46e-05	7.14e-05	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—prostate cancer	2.46e-05	7.13e-05	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—prostate cancer	2.44e-05	7.07e-05	CcSEcCtD
Ropinirole—Back pain—Epirubicin—prostate cancer	2.43e-05	7.04e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Capecitabine—prostate cancer	2.42e-05	7.03e-05	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—prostate cancer	2.42e-05	7.02e-05	CcSEcCtD
Ropinirole—Dizziness—Etoposide—prostate cancer	2.41e-05	7.01e-05	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—prostate cancer	2.41e-05	7e-05	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—prostate cancer	2.41e-05	6.99e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Capecitabine—prostate cancer	2.4e-05	6.97e-05	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—prostate cancer	2.4e-05	6.97e-05	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—prostate cancer	2.4e-05	6.96e-05	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—prostate cancer	2.4e-05	6.96e-05	CcSEcCtD
Ropinirole—Chills—Doxorubicin—prostate cancer	2.39e-05	6.94e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Prednisone—prostate cancer	2.38e-05	6.92e-05	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—prostate cancer	2.38e-05	6.91e-05	CcSEcCtD
Ropinirole—Insomnia—Prednisone—prostate cancer	2.37e-05	6.87e-05	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—prostate cancer	2.36e-05	6.86e-05	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—prostate cancer	2.36e-05	6.84e-05	CcSEcCtD
Ropinirole—Paraesthesia—Prednisone—prostate cancer	2.35e-05	6.82e-05	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—prostate cancer	2.34e-05	6.78e-05	CcSEcCtD
Ropinirole—Urticaria—Capecitabine—prostate cancer	2.33e-05	6.78e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—prostate cancer	2.33e-05	6.75e-05	CcSEcCtD
Ropinirole—Abdominal pain—Capecitabine—prostate cancer	2.32e-05	6.74e-05	CcSEcCtD
Ropinirole—Body temperature increased—Capecitabine—prostate cancer	2.32e-05	6.74e-05	CcSEcCtD
Ropinirole—Vomiting—Etoposide—prostate cancer	2.32e-05	6.74e-05	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—prostate cancer	2.32e-05	6.74e-05	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—prostate cancer	2.32e-05	6.73e-05	CcSEcCtD
Ropinirole—Agitation—Epirubicin—prostate cancer	2.3e-05	6.69e-05	CcSEcCtD
Ropinirole—Dyspepsia—Prednisone—prostate cancer	2.3e-05	6.69e-05	CcSEcCtD
Ropinirole—Rash—Etoposide—prostate cancer	2.3e-05	6.68e-05	CcSEcCtD
Ropinirole—Dermatitis—Etoposide—prostate cancer	2.3e-05	6.68e-05	CcSEcCtD
Ropinirole—Headache—Etoposide—prostate cancer	2.29e-05	6.64e-05	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—prostate cancer	2.29e-05	6.64e-05	CcSEcCtD
Ropinirole—Tension—Doxorubicin—prostate cancer	2.28e-05	6.61e-05	CcSEcCtD
Ropinirole—Decreased appetite—Prednisone—prostate cancer	2.28e-05	6.6e-05	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—prostate cancer	2.27e-05	6.6e-05	CcSEcCtD
Ropinirole—Malaise—Epirubicin—prostate cancer	2.26e-05	6.57e-05	CcSEcCtD
Ropinirole—Fatigue—Prednisone—prostate cancer	2.26e-05	6.55e-05	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—prostate cancer	2.25e-05	6.54e-05	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—prostate cancer	2.25e-05	6.54e-05	CcSEcCtD
Ropinirole—Syncope—Epirubicin—prostate cancer	2.25e-05	6.53e-05	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—prostate cancer	2.24e-05	6.52e-05	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—prostate cancer	2.24e-05	6.52e-05	CcSEcCtD
Ropinirole—Constipation—Prednisone—prostate cancer	2.24e-05	6.5e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—prostate cancer	2.24e-05	6.49e-05	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—prostate cancer	2.23e-05	6.48e-05	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—prostate cancer	2.22e-05	6.43e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—prostate cancer	2.2e-05	6.4e-05	CcSEcCtD
Ropinirole—Cough—Epirubicin—prostate cancer	2.19e-05	6.35e-05	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—prostate cancer	2.19e-05	6.35e-05	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—prostate cancer	2.18e-05	6.32e-05	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—prostate cancer	2.17e-05	6.31e-05	CcSEcCtD
Ropinirole—Nausea—Etoposide—prostate cancer	2.17e-05	6.3e-05	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—prostate cancer	2.17e-05	6.29e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Capecitabine—prostate cancer	2.16e-05	6.28e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisone—prostate cancer	2.16e-05	6.26e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—prostate cancer	2.15e-05	6.25e-05	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—prostate cancer	2.15e-05	6.23e-05	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—prostate cancer	2.14e-05	6.23e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Prednisone—prostate cancer	2.14e-05	6.21e-05	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—prostate cancer	2.14e-05	6.2e-05	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—prostate cancer	2.14e-05	6.2e-05	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—prostate cancer	2.14e-05	6.2e-05	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—prostate cancer	2.13e-05	6.19e-05	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—prostate cancer	2.13e-05	6.18e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.12e-05	6.16e-05	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—prostate cancer	2.11e-05	6.12e-05	CcSEcCtD
Ropinirole—Asthenia—Capecitabine—prostate cancer	2.11e-05	6.12e-05	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—prostate cancer	2.09e-05	6.07e-05	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—prostate cancer	2.09e-05	6.06e-05	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—prostate cancer	2.08e-05	6.05e-05	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—prostate cancer	2.08e-05	6.04e-05	CcSEcCtD
Ropinirole—Urticaria—Prednisone—prostate cancer	2.08e-05	6.04e-05	CcSEcCtD
Ropinirole—Pruritus—Capecitabine—prostate cancer	2.08e-05	6.03e-05	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—prostate cancer	2.08e-05	6.03e-05	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—prostate cancer	2.08e-05	6.03e-05	CcSEcCtD
Ropinirole—Abdominal pain—Prednisone—prostate cancer	2.07e-05	6.01e-05	CcSEcCtD
Ropinirole—Body temperature increased—Prednisone—prostate cancer	2.07e-05	6.01e-05	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—prostate cancer	2.06e-05	5.99e-05	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—prostate cancer	2.05e-05	5.95e-05	CcSEcCtD
Ropinirole—Oedema—Epirubicin—prostate cancer	2.05e-05	5.94e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—prostate cancer	2.04e-05	5.92e-05	CcSEcCtD
Ropinirole—Infection—Epirubicin—prostate cancer	2.03e-05	5.9e-05	CcSEcCtD
Ropinirole—Cough—Doxorubicin—prostate cancer	2.02e-05	5.88e-05	CcSEcCtD
Ropinirole—Shock—Epirubicin—prostate cancer	2.01e-05	5.85e-05	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—prostate cancer	2.01e-05	5.84e-05	CcSEcCtD
Ropinirole—Diarrhoea—Capecitabine—prostate cancer	2.01e-05	5.84e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—prostate cancer	2.01e-05	5.83e-05	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—prostate cancer	2.01e-05	5.83e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—prostate cancer	2e-05	5.82e-05	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—prostate cancer	2e-05	5.82e-05	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—prostate cancer	2e-05	5.8e-05	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—prostate cancer	1.99e-05	5.77e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—prostate cancer	1.98e-05	5.74e-05	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—prostate cancer	1.98e-05	5.73e-05	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—prostate cancer	1.98e-05	5.73e-05	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—prostate cancer	1.98e-05	5.73e-05	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—prostate cancer	1.97e-05	5.72e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.96e-05	5.7e-05	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—prostate cancer	1.95e-05	5.67e-05	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—prostate cancer	1.95e-05	5.66e-05	CcSEcCtD
Ropinirole—Dizziness—Capecitabine—prostate cancer	1.94e-05	5.64e-05	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—prostate cancer	1.93e-05	5.61e-05	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—prostate cancer	1.93e-05	5.6e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisone—prostate cancer	1.93e-05	5.6e-05	CcSEcCtD
Ropinirole—Rash—Docetaxel—prostate cancer	1.91e-05	5.55e-05	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—prostate cancer	1.91e-05	5.55e-05	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—prostate cancer	1.91e-05	5.55e-05	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—prostate cancer	1.91e-05	5.54e-05	CcSEcCtD
Ropinirole—Headache—Docetaxel—prostate cancer	1.9e-05	5.52e-05	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—prostate cancer	1.89e-05	5.5e-05	CcSEcCtD
Ropinirole—Infection—Doxorubicin—prostate cancer	1.88e-05	5.46e-05	CcSEcCtD
Ropinirole—Asthenia—Prednisone—prostate cancer	1.88e-05	5.45e-05	CcSEcCtD
Ropinirole—Vomiting—Capecitabine—prostate cancer	1.87e-05	5.42e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.86e-05	5.41e-05	CcSEcCtD
Ropinirole—Shock—Doxorubicin—prostate cancer	1.86e-05	5.41e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—prostate cancer	1.86e-05	5.39e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—prostate cancer	1.85e-05	5.38e-05	CcSEcCtD
Ropinirole—Rash—Capecitabine—prostate cancer	1.85e-05	5.38e-05	CcSEcCtD
Ropinirole—Pruritus—Prednisone—prostate cancer	1.85e-05	5.37e-05	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—prostate cancer	1.85e-05	5.37e-05	CcSEcCtD
Ropinirole—Dermatitis—Capecitabine—prostate cancer	1.85e-05	5.37e-05	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—prostate cancer	1.85e-05	5.37e-05	CcSEcCtD
Ropinirole—Headache—Capecitabine—prostate cancer	1.84e-05	5.34e-05	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—prostate cancer	1.84e-05	5.34e-05	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—prostate cancer	1.84e-05	5.34e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—prostate cancer	1.83e-05	5.31e-05	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—prostate cancer	1.82e-05	5.3e-05	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—prostate cancer	1.82e-05	5.28e-05	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—prostate cancer	1.81e-05	5.24e-05	CcSEcCtD
Ropinirole—Nausea—Docetaxel—prostate cancer	1.8e-05	5.23e-05	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—prostate cancer	1.8e-05	5.23e-05	CcSEcCtD
Ropinirole—Diarrhoea—Prednisone—prostate cancer	1.79e-05	5.2e-05	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—prostate cancer	1.78e-05	5.17e-05	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—prostate cancer	1.77e-05	5.14e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—prostate cancer	1.77e-05	5.13e-05	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—prostate cancer	1.76e-05	5.12e-05	CcSEcCtD
Ropinirole—Pain—Epirubicin—prostate cancer	1.75e-05	5.08e-05	CcSEcCtD
Ropinirole—Constipation—Epirubicin—prostate cancer	1.75e-05	5.08e-05	CcSEcCtD
Ropinirole—Nausea—Capecitabine—prostate cancer	1.75e-05	5.07e-05	CcSEcCtD
Ropinirole—Dizziness—Prednisone—prostate cancer	1.73e-05	5.02e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.73e-05	5.01e-05	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—prostate cancer	1.71e-05	4.97e-05	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—prostate cancer	1.7e-05	4.94e-05	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—prostate cancer	1.69e-05	4.9e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—prostate cancer	1.69e-05	4.9e-05	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—prostate cancer	1.68e-05	4.89e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—prostate cancer	1.67e-05	4.86e-05	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—prostate cancer	1.67e-05	4.84e-05	CcSEcCtD
Ropinirole—Vomiting—Prednisone—prostate cancer	1.66e-05	4.83e-05	CcSEcCtD
Ropinirole—Rash—Prednisone—prostate cancer	1.65e-05	4.79e-05	CcSEcCtD
Ropinirole—Dermatitis—Prednisone—prostate cancer	1.65e-05	4.79e-05	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—prostate cancer	1.65e-05	4.78e-05	CcSEcCtD
Ropinirole—Headache—Prednisone—prostate cancer	1.64e-05	4.76e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.64e-05	4.75e-05	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—prostate cancer	1.63e-05	4.74e-05	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—prostate cancer	1.63e-05	4.72e-05	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—prostate cancer	1.62e-05	4.7e-05	CcSEcCtD
Ropinirole—Pain—Doxorubicin—prostate cancer	1.62e-05	4.7e-05	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—prostate cancer	1.62e-05	4.7e-05	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—prostate cancer	1.62e-05	4.7e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—prostate cancer	1.56e-05	4.53e-05	CcSEcCtD
Ropinirole—Nausea—Prednisone—prostate cancer	1.55e-05	4.51e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.55e-05	4.5e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—prostate cancer	1.51e-05	4.38e-05	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—prostate cancer	1.5e-05	4.37e-05	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—prostate cancer	1.5e-05	4.35e-05	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—prostate cancer	1.5e-05	4.35e-05	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—prostate cancer	1.47e-05	4.26e-05	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—prostate cancer	1.45e-05	4.2e-05	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—prostate cancer	1.4e-05	4.07e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—prostate cancer	1.4e-05	4.05e-05	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—prostate cancer	1.36e-05	3.94e-05	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—prostate cancer	1.35e-05	3.93e-05	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—prostate cancer	1.34e-05	3.89e-05	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—prostate cancer	1.3e-05	3.78e-05	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—prostate cancer	1.3e-05	3.76e-05	CcSEcCtD
Ropinirole—Rash—Epirubicin—prostate cancer	1.29e-05	3.75e-05	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—prostate cancer	1.29e-05	3.74e-05	CcSEcCtD
Ropinirole—Headache—Epirubicin—prostate cancer	1.28e-05	3.72e-05	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—prostate cancer	1.25e-05	3.64e-05	CcSEcCtD
Ropinirole—Nausea—Epirubicin—prostate cancer	1.22e-05	3.53e-05	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—prostate cancer	1.2e-05	3.5e-05	CcSEcCtD
Ropinirole—Rash—Doxorubicin—prostate cancer	1.19e-05	3.47e-05	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—prostate cancer	1.19e-05	3.46e-05	CcSEcCtD
Ropinirole—Headache—Doxorubicin—prostate cancer	1.19e-05	3.44e-05	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—prostate cancer	1.12e-05	3.27e-05	CcSEcCtD
Ropinirole—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	2.75e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—prostate cancer	2.74e-06	1.98e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—prostate cancer	2.74e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—prostate cancer	2.74e-06	1.98e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	2.73e-06	1.97e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CTNNB1—prostate cancer	2.73e-06	1.97e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.73e-06	1.97e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CB—prostate cancer	2.72e-06	1.96e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAV1—prostate cancer	2.72e-06	1.96e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—prostate cancer	2.71e-06	1.96e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—prostate cancer	2.7e-06	1.95e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—prostate cancer	2.7e-06	1.95e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—prostate cancer	2.7e-06	1.95e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—prostate cancer	2.69e-06	1.94e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—prostate cancer	2.68e-06	1.94e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—prostate cancer	2.68e-06	1.94e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	2.68e-06	1.94e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—prostate cancer	2.68e-06	1.93e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.68e-06	1.93e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—prostate cancer	2.68e-06	1.93e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CB—prostate cancer	2.68e-06	1.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FGF2—prostate cancer	2.67e-06	1.93e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	2.67e-06	1.93e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—prostate cancer	2.66e-06	1.92e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CTNNB1—prostate cancer	2.66e-06	1.92e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ERCC2—prostate cancer	2.66e-06	1.92e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—prostate cancer	2.65e-06	1.92e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EP300—prostate cancer	2.64e-06	1.91e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GGT1—prostate cancer	2.64e-06	1.91e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—prostate cancer	2.64e-06	1.9e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—prostate cancer	2.61e-06	1.89e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—prostate cancer	2.61e-06	1.88e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—prostate cancer	2.61e-06	1.88e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NCOA1—prostate cancer	2.6e-06	1.88e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—prostate cancer	2.6e-06	1.88e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1A—prostate cancer	2.6e-06	1.87e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—prostate cancer	2.59e-06	1.87e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—prostate cancer	2.59e-06	1.87e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—prostate cancer	2.58e-06	1.86e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—prostate cancer	2.57e-06	1.86e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SRC—prostate cancer	2.57e-06	1.86e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.56e-06	1.85e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JAK2—prostate cancer	2.56e-06	1.85e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EP300—prostate cancer	2.55e-06	1.84e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1B—prostate cancer	2.55e-06	1.84e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—prostate cancer	2.55e-06	1.84e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—prostate cancer	2.55e-06	1.84e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EP300—prostate cancer	2.54e-06	1.83e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—prostate cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—prostate cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—prostate cancer	2.53e-06	1.83e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—prostate cancer	2.53e-06	1.82e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—prostate cancer	2.52e-06	1.82e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—prostate cancer	2.52e-06	1.82e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	2.51e-06	1.81e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	2.51e-06	1.81e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	2.5e-06	1.81e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MDM2—prostate cancer	2.5e-06	1.81e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—prostate cancer	2.5e-06	1.81e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—prostate cancer	2.5e-06	1.8e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—prostate cancer	2.5e-06	1.8e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—prostate cancer	2.5e-06	1.8e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—prostate cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SRC—prostate cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—prostate cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.48e-06	1.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—RXRA—prostate cancer	2.47e-06	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EP300—prostate cancer	2.47e-06	1.78e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SRC—prostate cancer	2.47e-06	1.78e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	2.47e-06	1.78e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—prostate cancer	2.46e-06	1.78e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—prostate cancer	2.46e-06	1.77e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARA—prostate cancer	2.45e-06	1.77e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—prostate cancer	2.45e-06	1.77e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—prostate cancer	2.45e-06	1.77e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—prostate cancer	2.44e-06	1.76e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—prostate cancer	2.43e-06	1.76e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	2.43e-06	1.76e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—prostate cancer	2.42e-06	1.75e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CTNNB1—prostate cancer	2.41e-06	1.74e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—prostate cancer	2.4e-06	1.74e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SRC—prostate cancer	2.4e-06	1.73e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—EP300—prostate cancer	2.4e-06	1.73e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—prostate cancer	2.4e-06	1.73e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—prostate cancer	2.4e-06	1.73e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—prostate cancer	2.39e-06	1.73e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—prostate cancer	2.39e-06	1.73e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—COMT—prostate cancer	2.38e-06	1.72e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—prostate cancer	2.38e-06	1.72e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	2.37e-06	1.71e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—prostate cancer	2.37e-06	1.71e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—prostate cancer	2.36e-06	1.71e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—prostate cancer	2.36e-06	1.7e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—prostate cancer	2.36e-06	1.7e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1A—prostate cancer	2.36e-06	1.7e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—prostate cancer	2.35e-06	1.7e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—INS—prostate cancer	2.34e-06	1.69e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	2.34e-06	1.69e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	2.34e-06	1.69e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ITPR1—prostate cancer	2.33e-06	1.69e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	2.33e-06	1.68e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—prostate cancer	2.33e-06	1.68e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	2.32e-06	1.67e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—prostate cancer	2.32e-06	1.67e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—prostate cancer	2.31e-06	1.67e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—prostate cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAV1—prostate cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CREBBP—prostate cancer	2.3e-06	1.66e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—prostate cancer	2.29e-06	1.66e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	2.28e-06	1.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	2.26e-06	1.63e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—prostate cancer	2.26e-06	1.63e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—prostate cancer	2.25e-06	1.63e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—prostate cancer	2.25e-06	1.63e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—prostate cancer	2.24e-06	1.62e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EP300—prostate cancer	2.24e-06	1.62e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—prostate cancer	2.24e-06	1.62e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—prostate cancer	2.24e-06	1.61e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—prostate cancer	2.22e-06	1.61e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—prostate cancer	2.22e-06	1.61e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—prostate cancer	2.22e-06	1.6e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—prostate cancer	2.21e-06	1.6e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—prostate cancer	2.21e-06	1.59e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—prostate cancer	2.21e-06	1.59e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EP300—prostate cancer	2.21e-06	1.59e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.2e-06	1.59e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—prostate cancer	2.2e-06	1.59e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—prostate cancer	2.19e-06	1.58e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—prostate cancer	2.18e-06	1.58e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—prostate cancer	2.18e-06	1.57e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—prostate cancer	2.18e-06	1.57e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SRC—prostate cancer	2.18e-06	1.57e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.18e-06	1.57e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—prostate cancer	2.18e-06	1.57e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—prostate cancer	2.17e-06	1.56e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—prostate cancer	2.16e-06	1.56e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—prostate cancer	2.16e-06	1.56e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	2.16e-06	1.56e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—prostate cancer	2.15e-06	1.55e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	2.15e-06	1.55e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SRC—prostate cancer	2.14e-06	1.55e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—LPL—prostate cancer	2.14e-06	1.54e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—prostate cancer	2.13e-06	1.54e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—prostate cancer	2.12e-06	1.53e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—prostate cancer	2.12e-06	1.53e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—prostate cancer	2.12e-06	1.53e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	2.11e-06	1.52e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—prostate cancer	2.11e-06	1.52e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—prostate cancer	2.1e-06	1.52e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—prostate cancer	2.1e-06	1.52e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.1e-06	1.51e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—prostate cancer	2.1e-06	1.51e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—prostate cancer	2.09e-06	1.51e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—prostate cancer	2.07e-06	1.49e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—prostate cancer	2.07e-06	1.49e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.07e-06	1.49e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—prostate cancer	2.06e-06	1.49e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—prostate cancer	2.06e-06	1.48e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—prostate cancer	2.06e-06	1.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	2.05e-06	1.48e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ERCC2—prostate cancer	2.05e-06	1.48e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—prostate cancer	2.04e-06	1.48e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—prostate cancer	2.02e-06	1.46e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EP300—prostate cancer	2.01e-06	1.45e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—prostate cancer	1.99e-06	1.44e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.99e-06	1.44e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—INS—prostate cancer	1.99e-06	1.43e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	1.96e-06	1.41e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—prostate cancer	1.95e-06	1.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.95e-06	1.41e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.95e-06	1.41e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CREBBP—prostate cancer	1.94e-06	1.4e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—prostate cancer	1.94e-06	1.4e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—prostate cancer	1.93e-06	1.39e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—prostate cancer	1.92e-06	1.39e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—prostate cancer	1.92e-06	1.38e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.92e-06	1.38e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—prostate cancer	1.91e-06	1.38e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.9e-06	1.37e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.9e-06	1.37e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.9e-06	1.37e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—prostate cancer	1.89e-06	1.37e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARA—prostate cancer	1.89e-06	1.36e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.89e-06	1.36e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.88e-06	1.36e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—prostate cancer	1.88e-06	1.36e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.88e-06	1.36e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.88e-06	1.36e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.84e-06	1.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—prostate cancer	1.83e-06	1.32e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—prostate cancer	1.82e-06	1.31e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—prostate cancer	1.8e-06	1.3e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—prostate cancer	1.79e-06	1.29e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—prostate cancer	1.78e-06	1.29e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAV1—prostate cancer	1.78e-06	1.28e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.78e-06	1.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.77e-06	1.28e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—prostate cancer	1.77e-06	1.28e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—prostate cancer	1.77e-06	1.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.75e-06	1.26e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.74e-06	1.26e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—prostate cancer	1.74e-06	1.26e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—prostate cancer	1.73e-06	1.25e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.71e-06	1.23e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—prostate cancer	1.67e-06	1.21e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—prostate cancer	1.66e-06	1.2e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.66e-06	1.2e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—prostate cancer	1.64e-06	1.18e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.62e-06	1.17e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—prostate cancer	1.62e-06	1.17e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1.62e-06	1.17e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.61e-06	1.16e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—prostate cancer	1.6e-06	1.16e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—prostate cancer	1.6e-06	1.15e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—prostate cancer	1.59e-06	1.15e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—prostate cancer	1.58e-06	1.14e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—EP300—prostate cancer	1.56e-06	1.13e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.54e-06	1.11e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—INS—prostate cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CREBBP—prostate cancer	1.5e-06	1.08e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—prostate cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	1.48e-06	1.07e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—prostate cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—prostate cancer	1.45e-06	1.05e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—prostate cancer	1.44e-06	1.04e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—prostate cancer	1.44e-06	1.04e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—prostate cancer	1.39e-06	1e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—prostate cancer	1.35e-06	9.78e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—prostate cancer	1.34e-06	9.7e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—prostate cancer	1.33e-06	9.62e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—EP300—prostate cancer	1.32e-06	9.56e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—prostate cancer	1.31e-06	9.49e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.24e-06	8.95e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—prostate cancer	1.23e-06	8.87e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—prostate cancer	1.21e-06	8.75e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.16e-06	8.35e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—prostate cancer	1.07e-06	7.74e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—EP300—prostate cancer	1.02e-06	7.38e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—prostate cancer	9.8e-07	7.07e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—prostate cancer	9.45e-07	6.82e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—prostate cancer	8e-07	5.78e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.56e-07	5.46e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—prostate cancer	6.18e-07	4.46e-06	CbGpPWpGaD
